metastatic tumor
We have investigated the effect of IFNs/IFO treatment on the expression of vascular endothelial growth factor (VEGF), matrix metalloproteinase 9 (MMP-9), and urokinase plasminogen activator receptor (uPAR), three key mediators of tumor growth and angiogenesis, in tumor xenografts generated either from a primary tumor (EW7) or from a metastatic tumor (COH).
We have investigated the effect of IFNs/IFO treatment on the expression of <span class="gene" id="15659795-5-75-109">vascular endothelial growth factor</span> (<span class="gene" id="15659795-5-111-115">VEGF</span>), matrix metalloproteinase 9 (MMP-9), and urokinase plasminogen activator receptor (uPAR), three key mediators of tumor growth and angiogenesis, in tumor xenografts generated either from a primary tumor (EW7) or from a <span class="disease" id="15659795-5-335-351">metastatic tumor</span> (COH).